These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 12774163)
1. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model. Ota T; Takamura T; Ando H; Nohara E; Yamashita H; Kobayashi K Diabetologia; 2003 Jun; 46(6):843-51. PubMed ID: 12774163 [TBL] [Abstract][Full Text] [Related]
2. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression. Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946 [TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Usui H; Shikata K; Matsuda M; Okada S; Ogawa D; Yamashita T; Hida K; Satoh M; Wada J; Makino H Nephrol Dial Transplant; 2003 Feb; 18(2):265-72. PubMed ID: 12543879 [TBL] [Abstract][Full Text] [Related]
7. Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics. Cooper ME; Allen TJ; O'Brien RC; Macmillan PA; Clarke B; Jerums G; Doyle AE J Hypertens; 1988 Dec; 6(12):1009-16. PubMed ID: 3221096 [TBL] [Abstract][Full Text] [Related]
8. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats. Tone A; Shikata K; Sasaki M; Ohga S; Yozai K; Nishishita S; Usui H; Nagase R; Ogawa D; Okada S; Shikata Y; Wada J; Makino H Diabetologia; 2005 Nov; 48(11):2402-11. PubMed ID: 16231067 [TBL] [Abstract][Full Text] [Related]
9. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958 [TBL] [Abstract][Full Text] [Related]
10. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Sassy-Prigent C; Heudes D; Mandet C; Bélair MF; Michel O; Perdereau B; Bariéty J; Bruneval P Diabetes; 2000 Mar; 49(3):466-75. PubMed ID: 10868970 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of a small dose of captopril on the reduction of glomerular basement membrane anionic sites in spontaneously hypertensive rats with streptozotocin-induced diabetes. Isogai S; Kameyama M; Iso K; Yoshino G J Diabetes Complications; 1998; 12(3):170-5. PubMed ID: 9618073 [TBL] [Abstract][Full Text] [Related]
12. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats. Yamashita T; Shikata K; Matsuda M; Okada S; Ogawa D; Sugimoto H; Wada J; Makino H Diabetes Res Clin Pract; 2002 Sep; 57(3):149-61. PubMed ID: 12126764 [TBL] [Abstract][Full Text] [Related]
13. Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats. Qi XM; Wu GZ; Wu YG; Lin H; Shen JJ; Lin SY Nephron Exp Nephrol; 2006; 104(4):e147-57. PubMed ID: 16902319 [TBL] [Abstract][Full Text] [Related]
14. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat. Cooper ME; Allen TJ; Macmillan PA; Clarke BE; Jerums G; Doyle AE Diabetologia; 1989 May; 32(5):326-8. PubMed ID: 2546846 [TBL] [Abstract][Full Text] [Related]
15. Influence of C-peptide on early glomerular changes in diabetic mice. Maezawa Y; Yokote K; Sonezaki K; Fujimoto M; Kobayashi K; Kawamura H; Tokuyama T; Takemoto M; Ueda S; Kuwaki T; Mori S; Wahren J; Saito Y Diabetes Metab Res Rev; 2006; 22(4):313-22. PubMed ID: 16389646 [TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of polyphenol-containing azuki bean (Vigna angularis) seed coats on the renal cortex in streptozotocin-induced diabetic rats. Sato S; Yamate J; Hori Y; Hatai A; Nozawa M; Sagai M J Nutr Biochem; 2005 Sep; 16(9):547-53. PubMed ID: 16115543 [TBL] [Abstract][Full Text] [Related]
18. Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes. Tang Z; Shou I; Wang LN; Fukui M; Tomino Y Nephron; 1997; 76(3):323-30. PubMed ID: 9226234 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous remission of diabetes arrests progression of nephropathy in streptozotocin-treated spontaneously hypertensive rats. Iwase M; Wakisaka M; Sato Y; Yoshinari M; Nunoi K; Ochi N; Fujishima M Diabetes Res Clin Pract; 1994 Jan; 22(2-3):129-37. PubMed ID: 8200294 [TBL] [Abstract][Full Text] [Related]
20. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Wang SN; LaPage J; Hirschberg R Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]